My hope is that these terms and labels grow in familiarity because of advancement in treatments and saved lives. For today, here is what we mean when we talk about a brain tumor:   • Glioblastoma multiforme (GBM) – This tumor forms in the white matter of the brain. GBM represents 52% of all cerebral [...]

Two federally designated cancer centers are embarking on an unusual alliance. As reported in the Boston Globe, researchers at the David H. Koch Institute for Integrative Cancer Research at MIT and the Dana-Farber/Harvard Cancer Center in Boston plan a new alliance to offer greater collaboration with the goal of developing new treatments for glioblastoma brain [...]

http://www.firstcoastnews.com/news/article/244707/483/New-Vaccine-Helping-Brain-Cancer-Patients This is a phase II clinical trial using heat shock protein vaccine (HSPPC-96) for patients with newly diagnosed glioblastoma multiforme (GBM). The trial employs cancer immunotherapy, an important new treatment modality, with HSPPC-96 being a novel approach to active specific immunotherapy. By targeting the immune system and activating a patient specific T-cell response, the vaccine [...]

This statement, by Jeff Kolodin, Chair of the National Brain Tumor Society Board of Directors, captures exactly where The Elliott Foundation is today. Jeff speaks from firsthand experience; first, as a 20-year brain tumor survivor, and second, as someone who has helped shepherd the NBTS through a two-year transition that changed the focus of the [...]

Hi Everyone. Something has been on my mind for the last several months, so today, I thought I would BLOG about it. I’ve been really slow over the last two months to respond to all the day-to-day patient & caregiver requests for help that come in and I wanted to explain why. If you’ve been [...]